A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Overweight/Obese Subjects

NCT06953063 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight and Obesity

Interventions

DRUG: DA-302168S
DRUG: Placebo of DA-302168S

Sponsor

Chendu DIAO Pharmaceutical Group CO., LTD.